Title: SENATE BILL 518 By: Alvord
Official Title: SENATE BILL 518 By: Alvord
Number of Sections: 14
Source: versions - Introduced
Media Type: application/pdf
Strikethrough Detection: 4 sections found

================================================================================

Section 1:
1
STATE OF OKLAHOMA
1
2
1st Session of the 60th Legislature (2025)
2
3
3
4
4
5
5
6
AS INTRODUCED
6
7
An Act relating to medical marijuana packaging;
7
amending 63 O.S. 2021, Section 427.18, as last
8
amended by Section 144, Chapter 452, O.S.L. 2024 (63
8
O.S. Supp. 2024, Section 427.18), which relates to
9
packaging and labeling requirements; requiring
9
certain labeling; and providing an effective date.
10
10
11
11
12
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
12
13

Section 2:
SECTION 1. AMENDATORY 63 O.S. 2021, Section 427.18, as
13
14
last amended by Section 144, Chapter 452, O.S.L. 2024 (63 O.S. Supp.
14
15
2024, Section 427.18), is amended to read as follows:
15
16

Section 3:
Section 427.18. A. A medical marijuana business shall not
16
17
sell, transfer or otherwise distribute medical marijuana or medical
17
18
marijuana product that has not been packaged and labeled in
18
19
accordance with this section and rules promulgated by the Executive
19
20
Director of the Oklahoma Medical Marijuana Authority.
20
21
B. A medical marijuana dispensary shall return medical
21
22
marijuana and medical marijuana product that does not meet packaging
22
23
or labeling requirements in this section or rules promulgated
23
24
pursuant thereto to the entity who transferred it to the dispensary.
24
Req. No. 18 Page 1
1
The medical marijuana dispensary shall document to whom the item was
1
2
returned, what was returned, and the date of the return, or dispose
2
3
of any usable marijuana that does not meet these requirements in
3
4
accordance with the Oklahoma Medical Marijuana and Patient
4
5
Protection Act.
5
6
C. 1. Medical marijuana packaging shall be packaged to
6
7
minimize its appeal to children and shall not depict images other
7
8
than the business name logo of the medical marijuana producer and
8
9
image of the product.
9
10

Section 4:
2. A medical marijuana business shall not place any content on
10
11
a container in a manner that reasonably appears to target
11
12
individuals under the age of twenty-one (21) including, but not
12
13
limited to, cartoon characters or similar images.
13
14

Section 5:
3. Labels on a container shall not include any false or
14
15
misleading statements.
15
16

Section 6:
4. No container shall be intentionally or knowingly labeled so
16
17
as to cause a reasonable patient confusion as to whether the medical
17
18
marijuana, medical marijuana concentrate or medical marijuana
18
19
product is a trademarked product or labeled in a manner that
19
20
violates any federal trademark law or regulation. The label on the
20
21
container shall include a warning that states the following:
21
22
a. “For use by licensed medical marijuana patients only”,
22
23
and
23
24
b. “Keep out of reach of children”., and
24
Req. No. 18 Page 2
1
c. “Marijuana and marijuana products can impair
1
2
concentration, coordination, and judgment: a person
2
3
should not operate a motor vehicle while under the
3
4
influence of marijuana or marijuana products. The
4
5
ingestion of any amount of marijuana or marijuana
5
6
products before driving may result in criminal
6
7
prosecution for driving under the influence.”
7
8

Section 7:
5. The label on the container shall not make any claims
8
9
regarding health or physical benefits to the patient.
9
10

Section 8:
6. The container itself may be clear in order to allow licensed
10
11
medical marijuana patients and licensed medical marijuana caregivers
11
12
the ability to view the product inside the container but shall be
12
13
child-resistant, as defined in Section 427.2 of this title.
13
14

Section 9:
7. At the point of sale and transfer of any medical marijuana,
14
15
medical marijuana concentrate, or medical marijuana products to a
15
16
licensed medical marijuana patient or licensed medical marijuana
16
17
caregiver, the dispensary shall place the medical marijuana, medical
17
18
marijuana concentrate, or medical marijuana products in an exit
18
19
package, as such term is defined in Section 427.2 of this title.
19
20
D. The Executive Director shall develop minimum standards for
20
21
packaging and labeling of medical marijuana, medical marijuana
21
22
concentrate, and medical marijuana products. Such standards shall
22
23
include, but not be limited to, the required contents of labels to
23
24
be affixed to all medical marijuana, medical marijuana concentrate,
24
Req. No. 18 Page 3
1
and medical marijuana products prior to transfer to a licensed
1
2
patient or caregiver, which shall include, at a minimum:
2
3

Section 10:
1. THC and other cannabinoid potency, and terpenoid potency;
3
4

Section 11:
2. A statement indicating that the product has been tested for
4
5
contaminants;
5
6

Section 12:
3. One or more product warnings to be determined by the
6
7
Executive Director; and
7
8

Section 13:
4. Any other information the Executive Director deems
8
9
necessary.
9
10

Section 14:
SECTION 2. This act shall become effective November 1, 2025.
10
11
11
12
60-1-18 CAD 1/19/2025 5:37:54 AM
12
13
13
14
14
15
15
16
16
17
17
18
18
19
19
20
20
21
21
22
22
23
23
24
24
Req. No. 18 Page 4
[DELETED:  P B A]
[DELETED:  P “ “]
[DELETED:  P “]
[DELETED:  P C 1]


================================================================================

Raw Text:
1
STATE OF OKLAHOMA
1
2
1st Session of the 60th Legislature (2025)
2
3
SENATE BILL 518 By: Alvord
3
4
4
5
5
6
AS INTRODUCED
6
7
An Act relating to medical marijuana packaging;
7
amending 63 O.S. 2021, Section 427.18, as last
8
amended by Section 144, Chapter 452, O.S.L. 2024 (63
8
O.S. Supp. 2024, Section 427.18), which relates to
9
packaging and labeling requirements; requiring
9
certain labeling; and providing an effective date.
10
10
11
11
12
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
12
13
SECTION 1. AMENDATORY 63 O.S. 2021, Section 427.18, as
13
14
last amended by Section 144, Chapter 452, O.S.L. 2024 (63 O.S. Supp.
14
15
2024, Section 427.18), is amended to read as follows:
15
16
Section 427.18. A. A medical marijuana business shall not
16
17
sell, transfer or otherwise distribute medical marijuana or medical
17
18
marijuana product that has not been packaged and labeled in
18
19
accordance with this section and rules promulgated by the Executive
19
20
Director of the Oklahoma Medical Marijuana Authority.
20
21
B. A medical marijuana dispensary shall return medical
21
22
marijuana and medical marijuana product that does not meet packaging
22
23
or labeling requirements in this section or rules promulgated
23
24
pursuant thereto to the entity who transferred it to the dispensary.
24
Req. No. 18 Page 1

1
The medical marijuana dispensary shall document to whom the item was
1
2
returned, what was returned, and the date of the return, or dispose
2
3
of any usable marijuana that does not meet these requirements in
3
4
accordance with the Oklahoma Medical Marijuana and Patient
4
5
Protection Act.
5
6
C. 1. Medical marijuana packaging shall be packaged to
6
7
minimize its appeal to children and shall not depict images other
7
8
than the business name logo of the medical marijuana producer and
8
9
image of the product.
9
10
2. A medical marijuana business shall not place any content on
10
11
a container in a manner that reasonably appears to target
11
12
individuals under the age of twenty-one (21) including, but not
12
13
limited to, cartoon characters or similar images.
13
14
3. Labels on a container shall not include any false or
14
15
misleading statements.
15
16
4. No container shall be intentionally or knowingly labeled so
16
17
as to cause a reasonable patient confusion as to whether the medical
17
18
marijuana, medical marijuana concentrate or medical marijuana
18
19
product is a trademarked product or labeled in a manner that
19
20
violates any federal trademark law or regulation. The label on the
20
21
container shall include a warning that states the following:
21
22
a. “For use by licensed medical marijuana patients only”,
22
23
and
23
24
b. “Keep out of reach of children”., and
24
Req. No. 18 Page 2

1
c. “Marijuana and marijuana products can impair
1
2
concentration, coordination, and judgment: a person
2
3
should not operate a motor vehicle while under the
3
4
influence of marijuana or marijuana products. The
4
5
ingestion of any amount of marijuana or marijuana
5
6
products before driving may result in criminal
6
7
prosecution for driving under the influence.”
7
8
5. The label on the container shall not make any claims
8
9
regarding health or physical benefits to the patient.
9
10
6. The container itself may be clear in order to allow licensed
10
11
medical marijuana patients and licensed medical marijuana caregivers
11
12
the ability to view the product inside the container but shall be
12
13
child-resistant, as defined in Section 427.2 of this title.
13
14
7. At the point of sale and transfer of any medical marijuana,
14
15
medical marijuana concentrate, or medical marijuana products to a
15
16
licensed medical marijuana patient or licensed medical marijuana
16
17
caregiver, the dispensary shall place the medical marijuana, medical
17
18
marijuana concentrate, or medical marijuana products in an exit
18
19
package, as such term is defined in Section 427.2 of this title.
19
20
D. The Executive Director shall develop minimum standards for
20
21
packaging and labeling of medical marijuana, medical marijuana
21
22
concentrate, and medical marijuana products. Such standards shall
22
23
include, but not be limited to, the required contents of labels to
23
24
be affixed to all medical marijuana, medical marijuana concentrate,
24
Req. No. 18 Page 3

1
and medical marijuana products prior to transfer to a licensed
1
2
patient or caregiver, which shall include, at a minimum:
2
3
1. THC and other cannabinoid potency, and terpenoid potency;
3
4
2. A statement indicating that the product has been tested for
4
5
contaminants;
5
6
3. One or more product warnings to be determined by the
6
7
Executive Director; and
7
8
4. Any other information the Executive Director deems
8
9
necessary.
9
10
SECTION 2. This act shall become effective November 1, 2025.
10
11
11
12
60-1-18 CAD 1/19/2025 5:37:54 AM
12
13
13
14
14
15
15
16
16
17
17
18
18
19
19
20
20
21
21
22
22
23
23
24
24
Req. No. 18 Page 4

[DELETED:  P B A]
[DELETED:  P “ “]
[DELETED:  P “]
[DELETED:  P C 1]